Bioharmony Therapeutics' Seed VC Round

Bioharmony Therapeutics raised a round of funding on December 18, 2017. Investors include Accelerate NY Seed Fund.

Bioharmony Therapeutics is a biopharmaceutical company focused on the discovery and development of lysin-based antimicrobial therapeutics for patients with multi-drug resistant Gram-negative bacterial…

Articles about Bioharmony Therapeutics' Seed VC Round: